Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology (Q36080911)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

multicenter clinical trial

0 references

medical oncology

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Laura Biganzoli

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

Maria Di Bartolomeo

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

author name string

R Buzzoni

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

E Bajetta

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

A Fornasiero

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

N Zilembo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

G Arcangeli

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

language of work or name

0 references

publication date

1 May 1995

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

British Journal of Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

71

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1111-1114

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

https://scigraph.springernature.com/pub.10.1038/bjc.1995.215

0 references

Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

2 October 2017

The Christie hospital adjuvant tamoxifen trial--status at 10 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

2 October 2017

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

2 October 2017

Clinical use of aromatase inhibitors: current data and future perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

2 October 2017

Tamoxifen in premenopausal patients with metastatic breast cancer: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

2 October 2017

Assessment of response to therapy in advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

2 October 2017

Optimal two-stage designs for phase II clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

11 July 2018

Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

11 July 2018

Combined goserelin and tamoxifen in premenopausal advanced breast cancer: duration of response and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

11 July 2018

Goserelin depot in the treatment of premenopausal advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033795

11 July 2018

Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endocrinological evaluation of bilateral and unilateral oophorectomy in premenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical castration produced by the GnRH analogue leuprolide to treat metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocrinologic and clinical evaluation following a single administration of a gonadotrophin-releasing hormone agonist (Zoladex), in a depot formulation, to premenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Goserelin in Premenopausal Advanced Breast Cancer: Clinical and Endocrine Evaluation of Responsive Patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/7734310

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1995.215

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7734310%20AND%20SRC:MED&resulttype=core&format=json

24 October 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36080911&oldid=1962146421"